Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin Hernández-Espinosa D, Miñano A, Martínez C, Ordoñez A, Pérez-Ceballos E, de Arriba F, Mota RA, Ferrer F, González M, Vicente V, Corral J. Laboratory Investigation 88(3):306-17. FI: 4.602 (Q1) Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA group Sanz MA, Montesinos P, Vellenga E, Rayón C, de la Serna J, Parody R, Bergua JM, León A, Negri S, González M, Rivas C, Esteve J, Milone G, González JD, Amutio E, Brunet S, García-Laraña J, Colomer D, Calasanz MJ, Chillón C, Barragán E, Bolufer P, Lowenberg B. Blood 112(8):3130-4. FI: 10.555 (Q1) - Morschhauser F, Radford J, Van Hoof A, Vitolo U, Soubeyran P, Tilly H, Huijgens PC, Kolstad A, d'Amore F, Phase III Randomized Study of Consolidation Therapy with 90Y-Ibritumomab Tiuxetan after First Remission in Advanced Follicular Lymphoma González M, Petrini M, Sebban C, Zinzani PL, van Oers MH, van Putten W, Bischof-Delaloye A, Rohatiner A,Salles G, Kuhlmann J, Hagenbeek A. Journal of Clinical Oncology 26(32):5156-64. FI: 17.793 (Q1) Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma Armellini A, Sarasquete ME, García-Sanz R, Chillón MC, Balanzategui A, Alcoceba M, Fuertes M, López R, Hernández JM, Fernández-Calvo J, Sierra M, Megido M, Orfao A, Gutiérrez NC, González M, San Miguel JF. British Journal of Haematology 141:212-5. FI: 4.597 (Q1) Association between the proliferative rate of neoplastic B-cells, their maturation stage and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patients Quijano S, López A, Rasillo A, Barrena S, Sánchez ML, Flores J, Fernández C, Sayagues JM, Osuna CS, Fernández N, González M, Giraldo P, Giralt M, Pérez MC, Martin-Antoran JM, Gutiérrez O, Perdiguer L, Diaz Mediavilla J, González Silva M, Asensio del Rio A, Cervero C, Guerra JL, Butrón R, Garcia MC, Almeida J, and Orfao A. Blood 111(10):5130-41. FI: 10.555 (Q1) The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease Alcoceba M, Marín L, Balanzategui A, Sarasquete ME, Martín-Jiménez P, Chillón MC, Corral R, Pérez-Persona E, Fernández-Calvo FJ, Hernández JM, Bladé J, Lahuerta JJ, González M, San Miguel JF, García-Sanz R. Tissue Antigens 71:548-551. FI: 2.330 (Q2) Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis Sarasquete ME, García-Sanz R, Marín L, Alcoceba M, Chillón MC, Balanzategui A, Santamaria C, Rosiñol L, de la Rubia J, Hernandez MT, Garcia-Navarro I, Lahuerta JJ, González M, San Miguel JF. Blood 112:2709-2712. FI: 10.555 (Q1) The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia Santamaría C, Chillón MC, García-Sanz R, Balanzategui A, Sarasquete ME, Alcoceba M, Ramos F, Bernal T, Queizán JA, Peñarrubia MJ, Giraldo P, San Miguel JF, Gonzalez M. Haematologica 93(12):1797-805. FI: 6.416 (Q1) Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in HLA identical allogeneic transplantation setting Alcoceba M, Balanzategui A, Díez-Campelo M, Martín-Jiménez P, Sarasquete ME, Chillón MC, Santamaría C, Pérez-Simón JA, Marín L, Caballero MD, San Miguel JF, García-Sanz R, González M. Transplantation 86:983-990. FI: 3.498 (Q1) Expanded cells in monoclonal TCR . /CD4. /NKa. /CD8-/ dim T-LGL lymphocytosis recognize hCMV antigens Rodríguez-Caballero A, García-Montero AC, Bárcena P, Almeida J, Ruiz-Cabello F, Tabernero MD, Garrido P, Muñoz-Criado S, Sandberg Y, Langerak AW, González M, Balanzategui A, Orfao A. Blood 112:4609-4616. FI: 10.555 (Q1)
|
